MGI RAISES $16.5 MILLION IN OFFERING

MGI Pharma Inc., which acquires and develops therapeutics forcancer and other diseases, on Friday said it completed a 2million-share secondary offering of common stock priced at$8.25, raising $16.5 million. Stock in the Minneapolis-basedcompany (NASDAQ:MOGN) closed at $8.38, down 13 cents, onFriday.

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

Today's news in brief

BioWorld

BioWorld briefs for April 21.

Somalogic to merge with CM Life Sciences II SPAC, as trendy IPO path continues

BioWorld MedTech

Somalogic Inc. has agreed to go public via a merger with blank-check company CM Life Sciences II. Upon closing, CMLS II – a special purpose acquisition company...

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for April 21.

Global cases rise, but more weapons advance to combat COVID-19

BioWorld

As COVID-19 vaccinations continue to roll out, momentum builds with strong phase III data for what could become the fourth and fifth walls of defense in the U.S.